FDA
-
-
-
-
-
-
-
Ekso Bionics (EKSO) Receives FDA Clearance to Market its EksoNR Robotic Exoskeleton for Use with Multiple Sclerosis Patients
-
-
-
-
-
-
-
Ekso Bionics® Releases its Upgraded EksoPulse Platform, Advanced Cloud-Based Analytics for Robotic Exoskeleton-Assisted Rehabilitation
-
-
-
-
-
-
-
Kindred Hospital Rehabilitation Services Expands Pilot of Ekso Bionics®’ EksoGT Exoskeleton to Enhance Stroke Rehabilitation Offering
-
-
-
-
-
-
-
International Journal Spinal Cord Publishes Multicenter Pan-Euro Study of EksoGT™
-
-
-
-
-
-
-
Ekso Bionics® Announces Centers of Robotic Excellence Collaborating with Rehabilitation Facilities for Mobility Impaired
-
-
-
-
-
-
-
Ekso Bionics® Launches EksoPulse Cloud-Based Analytics
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

